US2004151763A1PendingUtilityA1
Wipe formulation
Est. expiryOct 1, 2021(expired)· nominal 20-yr term from priority
Inventors:Catherine Durden
A61P 15/00A61P 15/02A61P 13/02A61P 13/00A61Q 19/00A61K 8/9789A61K 8/365A61K 8/0208A61K 9/0034A61K 2800/75
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a liquid formulation for a feminine wipe. The preferred formulation has an anti-irritant agent, a pH adjuster namely citric acid, and at least one preservative.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A liquid formulation for a wipe comprising an anti-irritant agent, citric acid, and at least one preservative.
2 . The formulation of claim 1 , wherein said anti-irritant agent is selected from the group consisting of anesthetic, analgesic, antipruitic, astringent, hydrocortisone preparation, keratolytic, and any combinations thereof.
3 . The formulation of claim 1 , wherein said anti-irritant agent is at least one local anesthetic selected from the group consisting of: benzocaine, benzyl alcohol, dibucaine, dibucaine HCl, Dyclonine HCl, Lidocaine, Pramoxine HCl, Tetracaine, Tetracaine HCl, and any combinations thereof.
4 . The formulation of claim 1 , wherein said anti-irritant agent is at least one analgesic, anesthetic, or antipruitic selected from the group consisting of camphor, juniper tar, menthol, and any combinations thereof.
5 . The formulation of claim 1 , wherein said anti-irritant agent is at least one hydrocortisone derivative selected from the group consisting of hydrocortisone, hydrocortisone acetate, and any combination thereof.
6 . The formulation of claim 1 , wherein said anti-irritant agent is at least one keratolytic selected from the group consisting of alcloxa, resorcinol, and any combination thereof.
7 . The formulation of claim 1 , wherein said anti-irritant agent is at least one astringent selected from the group consisting of witch hazel, calamine, zinc oxide, and any combinations thereof.
8 . The formulation of claim 1 , wherein said anti-irritant agent is witch hazel.
9 . The formulation of claim 1 , wherein said anti-irritant agent is present in an amount from about 1 wt % up to about 50 wt % of the total weight of the formulation.
10 . The formulation of claim 9 , wherein said anti-irritant agent is present in an amount about 9 wt % of the total weight of the formulation.
11 . The formulation of claim 1 , wherein said citric acid is present in an amount from 0.01 wt % to 1 wt % of the total weight of the formulation.
12 . The formulation of claim 1 , wherein the formulation is in a pH range from about 4.0 to about 6.0.
13 . The formulation of claim 1 , wherein said at least one preservative is present in an amount from about 0.2 wt % to about 2 wt % of the total weight of the formulation.
14 . The formulation of claim 1 , wherein said at least one preservative is sodium hydroxymethylglycinate.
15 . The formulation of claim 1 , further comprising a humectant selected from the group consisting of glycerol, propylene glycol, sorbitol urea, amino acid, polyol, other compounds with hygroscopic properties, and any combinations thereof.
16 . The formulation of claim 15 , wherein said humectant is present in an amount from about 0.1 wt % to about 2 wt % of the total weight of the formulation.
17 . The formulation of claim 1 , further comprising a surfactant selected from the group consisting of alkylamido alkylamine, quaternary ammonium compound, phosphorus derivative, amphoteric imidazoline derivative, fatty sulfosuccinate ester and amide, ethoxylated sorbitan ester, betaine, alkoxylated alcohol, alkyl ether sulfate, disodium cocoamphodiacetate, cocamidopropyl betaine, PEG-80 glyceryl cocoate/PEG-30 glyceryl cocoate, decyl polyglucose, and any combinations thereof
18 . The formulation of claim 17 , wherein said surfactant is present in an amount greater than about 0 wt % to about 1 wt % of the total weight of the formulation.
19 . The formulation of claim 1 , further comprising a skin conditioning agent selected from the group consisting of botanical extract, ester, quaternary ammonium compound, asymmetrical carbonate, N-substituted carboxamide, urea, phosphine oxide, organic salt, and any combinations thereof.
20 . The formulation of claim 19 , wherein the skin conditioning agent is in an amount greater than about 0 wt % up to about 1.25 wt % of the total weight of the formulation.
21 . The formulation of claim 1 , further comprising an emulsifying agent selected from the group consisting of: sorbitan, alkoxylated fatty alcohol, alkylpolyglycoside, soap, alkyl sulfate, monoalkyl and dialkyl phosphate, alkyl sulphonate, acyl isothionate, and any combinations thereof.
22 . The formulation of claim 21 , wherein the emulsifying agent is in an amount greater than about 0 wt % to about 1 wt % of the total weight of the formulation.
23 . The formulation of claim 1 , further comprising a second preservative that combats mold.
24 . The formulation of claim 23 , wherein said second preservative is in an amount from about 0.1 wt % to about 0.3 wt % of the total weight of the formulation.
25 . The formulation of claim 23 , wherein said second preservative is potassium sorbate.
26 . The formulation of claim 1 , further comprising a chelating agent selected from the group consisting of disodium EDTA, ethylene-diamine-tetra-acetic acid, (ethylenedioxy)-diethlyene-dinitrilo-tetra-acetic acid, salicylaldoxime, quinolinol, triethylenetetramine, and any combinations thereof.
27 . The formulation of claim 26 , wherein said chelating agent is present in an amount greater than about 0 wt % up to about 0.2 wt % of the total weight of the formulation.
28 . The formulation of claim 1 , further comprising a fragrance.
29 . A liquid formulation for a wipe comprising citric acid, at least one preservative and an anti-irritant agent derived from a family selected from a group consisting of local anesthetic, analgesic, anesthetic, antipruitic, astringent, hydrocortisone preparation, and keratolytic, and any combinations thereof, wherein the wipe is a feminine wipe.Join the waitlist — get patent alerts
Track US2004151763A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.